Clinical and laboratory findings in 104 patients with prosthetic valve endocarditis (PVE)
| All patients (n = 104) | Early group (n = 20) | Late group (n = 84) | p Value | |
|---|---|---|---|---|
| Hb, haemoglobin; NYHA, New York Heart Association. | ||||
| Age (years) | 60 (16) | 57 (18) | 62 (15) | 0.19 |
| Men | 70 (67%) | 13 (65%) | 57 (68%) | 0.72 |
| Type of valve | ||||
| Bioprosthetic | 60 (57%) | 7 (35%) | 53 (64%) | |
| Mechanical | 39 (37%) | 10 (50%) | 29 (34%) | 0.016 |
| Homograft | 5 (5%) | 3 (15%) | 2 (2%) | |
| Valve location | ||||
| Mitral | 36 (35%) | 8 (40%) | 28 (34%) | 0.6 |
| Aortic | 68 (65%) | 12 (60%) | 56 (66%) | 0.6 |
| Co-morbidity ⩾1 | 55 (53%) | 11 (55%) | 44 (53%) | 0.83 |
| Co-morbidity ⩾2 | 14 (13%) | 3 (15%) | 11 (13%) | 1 |
| Fever | 99 (95%) | 19 (95%) | 80 (96%) | 1 |
| New or changing murmur | 46 (44%) | 9 (45%) | 37 (46%) | 0.95 |
| Osler’s nodes, Janeway | 3 (3%) | 1 (5%) | 2 (2%) | 1 |
| NYHA III–IV | 32 (31%) | 7 (35%) | 25 (30%) | 0.65 |
| Renal failure | 33 (32%) | 6 (30%) | 27 (32%) | 0.86 |
| Leucocytosis >109/l | 46 (44%) | 13 (65%) | 33 (30%) | 0.008 |
| Anaemia (Hb <6.2 mmol/l) | 38 (37%) | 3 (15%) | 35 (42%) | 0.046 |